Contact Us

HOTEL NEWS

Quantinuum Unveils Accelerated Roadmap to Achieve Universal, Fault-Tolerant Quantum Computing by 2030

Sep 11, 2024

With thousands of physical qubits,hundreds of logical qubits,low error rates,and a fully integrated software stack,Quantinuum\'s roadmap outlines its path to achieve scientific advantage and a tipping

Relativity Deepens its Chicagoland Roots with CPS Academic Investment and New Headquarters

Sep 11, 2024

Relativity aims to cultivate Chicago\'s future tech talent through enhanced CPS partnership CHICAGO,Sept. 10,2024-- Relativity,a global legal technology company,today announced that it has strengthene

Study Shows Ubie Symptom Checker Accuracy Rivals Physicians, Outperforms Competitors In Providing Disease Information

Sep 11, 2024

Results show Ubie\'s differential diagnosis platform had a Top-5 hit accuracy of 63.4% and a Top-10 hit accuracy of 71.6%; median physician accuracy was 72.9%

Retail golden quarter: how AI can boost sales success for retailers

Sep 11, 2024

New DeepL white paper underscores how Language AI will enable retailers to reduce costs and grow revenue through better internal and external communication

Innovent Delivers Oral Presentation on Phase 1 Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer at the 2024 WCLC

Sep 11, 2024

SAN FRANCISCOand SUZHOU,China,Sept. 11,2024-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical company that develops,manufactures and commercializes high-qu

'Highly Accurate': Telix's Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

Sep 11, 2024

MELBOURNE,Australia,Sept. 11,2024-- Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company) today announces that primary results from its Phase III ZIRCON[1] trial have been published in The Lance

1 ... 282 283 284 285 286 287 288 ... 349